Close Menu

In early online publication in Nature, Harvard's Bill Hahn is senior author on work that used an RNAi screen to find synthetic lethal partners of oncogenic KRAS -- "gene products that, when inhibited, result in cell death only in the presence of an oncogenic allele." They found that the IkappaB kinase TBK1 was needed in cells with mutant KRAS, and by suppressing this gene they induced apoptosis in human cancer cells that depend on oncogenic KRAS expression.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.